Krogulec Marek - Rheumatol Clin, MAK MED

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 23 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

CT-P17 Adalimumab Biosimilar in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: an Open-Label Extension of a Phase 3 Interchangeability Study

David M. Pariser,Mark G. Lebwohl, Janusz Jaworski,Jakub Trefler, Stefan Daniluk,Anna Dudek,Wojciech Baran, Witold Owczarek, Pawel Brzewski, Mariusz Sikora,Marek Krogulec, SungHyun Kim, JeeHye Suh, EunJin Choi, JungBin Cha, HyunJin Lee, SungJeong Lee, John Y. Koo

Dermatology and Therapyno. 5 (2025): 1079-1092

Cited0Views0WOSBibtex

Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study

Mark G. Lebwohl, John Y. Koo,Janusz Jaworski,Jakub Trefler, Stefan Daniluk,Anna Dudek,Wojciech Baran,Witold Owczarek, Joanna Kolinek,Paweł Brzewski, Mariusz Sikora,Marek Krogulec,SungHyun Kim,YunJu Bae,DaBee Jeon,EunJin Choi,JungBin Cha, HyunJin Lee, SuJin Choi,David M. Pariser

Advances in Therapyno. 3 (2025): 1582-1599

Cited0Views0WOSBibtex

Smolen J.S.,Trefler J.,Racewicz A.,Jaworski J.,Zielinska A.,Krogulec M.,Jeka S., Wojciechowski R.,Kolossa K., Dudek A., Krajewska-Włodarczyk M.,Hrycaj P., Klimiuk P.A.,Burmester G.R., Kim S.H.,Bae Y., Jeon D., Yang G., Jung Y., Hong J.

Annals of the Rheumatic Diseases (2024): 749-750

Cited0Views0Bibtex

Gerd Burmester,Jakub Trefler,Artur Racewicz,Janusz Jaworski,Agnieszka Zielinska,Marek Krogulec,Slawomir Jeka,Rafal Wojciechowski,Katarzyna Kolossa,Anna Dudek,Magdalena Krajewska-Wlodarczyk,Pawel Hrycaj,Piotr Adrian Klimiuk,SungHyun Kim,JeeHye Suh,Goeun Yang, Yunah Kim,YooBin Jung, Jiwoo Hong,Josef Smolen

ARTHRITIS & RHEUMATOLOGY (2024): 1017-1019

Cited0Views0Bibtex

Safety and Efficacy of the Mir-124 Upregulator ABX464 (obefazimod, 50 and 100 Mg Per Day) in Patients with Active Rheumatoid Arthritis and Inadequate Response to Methotrexate And/or Anti-Tnfα Therapy: a Placebo-Controlled Phase II Study

Claire Daien,Marek Krogulec,Paul Gineste,Jean-Marc Steens, Laurence Desroys du Roure,Sophie Biguenet,Didier Scherrer,Julien Santo,Hartmut Ehrlich,Patrick Durez

Annals of the Rheumatic Diseases（2022）

Cited21Views0WOSBibtex

POS0688 PHASE 2A STUDY IN PATIENTS WITH MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO MTX AND/OR ANTI-TNFΑ THERAPEUTICS SHOWS THAT ORAL ABX464 50 MG ONCE DAILY IS SAFE, WELL TOLERATED AND SHOWS PROMISING EFFICACY RESULTS

C. Daien,M. Krogulec,P. Gineste,J. M. Steens, L. Desroys Du Roure, S. Biguenet,D. Scherrer,J. Santo,H. Ehrlich,P. Durez

ANNALS OF THE RHEUMATIC DISEASES（2022）

Cited0Views0Bibtex

AB0198 EFFICACY AND SAFETY AFTER TRANSITION FROM REFERENCE ADALIMUMAB TO CT-P17 (ADALIMUMAB BIOSIMILAR: 100 MG/ML) IN COMPARISON WITH THE MAINTAINED TREATMENT (CT-P17 OR REFERENCE ADALIMUMAB) IN PATIENTS WITH MODERATE-TO-SEVERE ACTIVE RHEUMATOID ARTHRITIS: 1-YEAR RESULT

D. Furst,E. Keystone,J. Kay,J. Jaworski, R. Wojciechowski,P. Wiland, A. Dudek,M. Krogulec,S. Jeka,A. Zielinska, J. Trefler, K. Bartnicka-Maslowska, M. Krajewska-Wlodarczyk,P. Klimiuk,S. J. Lee,S. H. Kim,Y. Bae, G. Yang, J. Yoo,T. Kim

ANNALS OF THE RHEUMATIC DISEASES（2021）

Cited1Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn